RECRUITINGINTERVENTIONAL
Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
Pilot Study to Investigate the Use of Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises
About This Trial
This study aims to evaluate the use of virtual reality as an adjunct to standard care for patients with sickle cell disease experiencing vaso-occlusive crises.
Who May Be Eligible (Plain English)
Who May Qualify:
- Adult (age \> 18 years) emergency department patient
- History of sickle cell disease
- Presenting to the emergency department due to acute pain related to sickle cell disease thought to be due to vaso-occlusive crisis
Who Should NOT Join This Trial:
- Prior enrollment in this study
- Presenting with a chief complaint suggestive of a complicated crisis (such as concern for acute chest syndrome, splenic sequestration, hepatic sequestration, pulmonary embolism) as determined by the clinical care provider
- Not being treated with intravenous opioids for the vaso-occlusive crisis
- Patients who lack the capacity to provide willing to sign a consent form
- Medical history of seizures or known intolerance to virtual reality
- Disabilities like vision and hearing defects etc. that preclude the use of a head mounted virtual reality device.
- Known to be pregnant
- Incarcerated at the time of evaluation
- Over the age of 89 years old
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Adult (age \> 18 years) emergency department patient
* History of sickle cell disease
* Presenting to the emergency department due to acute pain related to sickle cell disease thought to be due to vaso-occlusive crisis
Exclusion Criteria:
* Prior enrollment in this study
* Presenting with a chief complaint suggestive of a complicated crisis (such as concern for acute chest syndrome, splenic sequestration, hepatic sequestration, pulmonary embolism) as determined by the clinical care provider
* Not being treated with intravenous opioids for the vaso-occlusive crisis
* Patients who lack the capacity to provide informed consent
* Medical history of seizures or known intolerance to virtual reality
* Disabilities like vision and hearing defects etc. that preclude the use of a head mounted virtual reality device.
* Known to be pregnant
* Incarcerated at the time of evaluation
* Over the age of 89 years old
Treatments Being Tested
DEVICE
Virtual Reality Headset and Hand-Held Controllers
Study Group-Virtual reality headset and hand-held controllers will be used as an adjuvant to pain management care.
OTHER
Blindfolding and Noise Cancelling
Control group-Blindfold and noise cancelling headphones will be a placebo comparator group to the experimental interventions of virtual reality devices.
Locations (1)
University of Maryland Medical Systems
Baltimore, Maryland, United States